616 results on '"A. Timbs"'
Search Results
2. A Call to Action to Improve Cardiac Arrest Outcomes: A Report From the National Summit for Cardiac Arrest
- Author
-
La Gerche, Andre, Paratz, Elizabeth D., Bray, Janet E., Jennings, Garry, Page, Greg, Timbs, Susan, Vandenberg, Jamie I., Abhayaratna, Walter, Chow, Clara K., Dennis, Mark, Figtree, Gemma A., Kovacic, Jason C., Maris, Jessica, Nehme, Ziad, Parsons, Sarah, Pflaumer, Andreas, Puranik, Rajesh, Stub, Dion, Freitas, Edwin, Zecchin, Robert, Cartledge, Susie, Haskins, Brian, and Ingles, Jodie
- Published
- 2024
- Full Text
- View/download PDF
3. FROM PIXELS TO PERFORMANCE: HARNESSING THE POWER OF STORAGE IN AI-DRIVEN MEDIA WORKFLOWS
- Author
-
Timbs, Alex
- Subjects
Video games ,Business ,Economics - Abstract
Imagine a digital revolution where creativity and efficiency collide. From blockbuster movies to video games, AI is transforming media production. Beyond the GPU, the secret helping to drive this change? [...]
- Published
- 2024
4. Compassionate Use of Remdesivir for Patients with Severe Covid-19
- Author
-
Grein, Jonathan, Ohmagari, Norio, Shin, Daniel, Diaz, George, Asperges, Erika, Castagna, Antonella, Feldt, Torsten, Green, Gary, Green, Margaret L, Lescure, François-Xavier, Nicastri, Emanuele, Oda, Rentaro, Yo, Kikuo, Quiros-Roldan, Eugenia, Studemeister, Alex, Redinski, John, Ahmed, Seema, Bernett, Jorge, Chelliah, Daniel, Chen, Danny, Chihara, Shingo, Cohen, Stuart H, Cunningham, Jennifer, D'Arminio Monforte, Antonella, Ismail, Saad, Kato, Hideaki, Lapadula, Giuseppe, L'Her, Erwan, Maeno, Toshitaka, Majumder, Sumit, Massari, Marco, Mora-Rillo, Marta, Mutoh, Yoshikazu, Nguyen, Duc, Verweij, Ewa, Zoufaly, Alexander, Osinusi, Anu O, DeZure, Adam, Zhao, Yang, Zhong, Lijie, Chokkalingam, Anand, Elboudwarej, Emon, Telep, Laura, Timbs, Leighann, Henne, Ilana, Sellers, Scott, Cao, Huyen, Tan, Susanna K, Winterbourne, Lucinda, Desai, Polly, Mera, Robertino, Gaggar, Anuj, Myers, Robert P, Brainard, Diana M, Childs, Richard, and Flanigan, Timothy
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Emerging Infectious Diseases ,Lung ,Clinical Trials and Supportive Activities ,Clinical Research ,Prevention ,Infectious Diseases ,6.1 Pharmaceuticals ,Evaluation of treatments and therapeutic interventions ,Good Health and Well Being ,Adenosine Monophosphate ,Administration ,Intravenous ,Adult ,Aged ,Aged ,80 and over ,Alanine ,Antiviral Agents ,Betacoronavirus ,COVID-19 ,Canada ,Compassionate Use Trials ,Coronavirus Infections ,Europe ,Female ,Humans ,Japan ,Male ,Middle Aged ,Pandemics ,Pneumonia ,Viral ,Respiration ,Artificial ,SARS-CoV-2 ,United States ,Young Adult ,COVID-19 Drug Treatment ,Medical and Health Sciences ,General & Internal Medicine ,Biomedical and clinical sciences ,Health sciences - Abstract
BackgroundRemdesivir, a nucleotide analogue prodrug that inhibits viral RNA polymerases, has shown in vitro activity against SARS-CoV-2.MethodsWe provided remdesivir on a compassionate-use basis to patients hospitalized with Covid-19, the illness caused by infection with SARS-CoV-2. Patients were those with confirmed SARS-CoV-2 infection who had an oxygen saturation of 94% or less while they were breathing ambient air or who were receiving oxygen support. Patients received a 10-day course of remdesivir, consisting of 200 mg administered intravenously on day 1, followed by 100 mg daily for the remaining 9 days of treatment. This report is based on data from patients who received remdesivir during the period from January 25, 2020, through March 7, 2020, and have clinical data for at least 1 subsequent day.ResultsOf the 61 patients who received at least one dose of remdesivir, data from 8 could not be analyzed (including 7 patients with no post-treatment data and 1 with a dosing error). Of the 53 patients whose data were analyzed, 22 were in the United States, 22 in Europe or Canada, and 9 in Japan. At baseline, 30 patients (57%) were receiving mechanical ventilation and 4 (8%) were receiving extracorporeal membrane oxygenation. During a median follow-up of 18 days, 36 patients (68%) had an improvement in oxygen-support class, including 17 of 30 patients (57%) receiving mechanical ventilation who were extubated. A total of 25 patients (47%) were discharged, and 7 patients (13%) died; mortality was 18% (6 of 34) among patients receiving invasive ventilation and 5% (1 of 19) among those not receiving invasive ventilation.ConclusionsIn this cohort of patients hospitalized for severe Covid-19 who were treated with compassionate-use remdesivir, clinical improvement was observed in 36 of 53 patients (68%). Measurement of efficacy will require ongoing randomized, placebo-controlled trials of remdesivir therapy. (Funded by Gilead Sciences.).
- Published
- 2020
5. Member insight: A long life of service to a community
- Author
-
Hava, Chloe and Timbs, Patrick
- Published
- 2021
6. Divided by the Word: Colonial Encounters and the Remaking of Zulu and Xhosa Identities by Jochen S. Arndt (review)
- Author
-
Timbs, Liz
- Published
- 2023
7. Radioactivity in Future Phosphogypsum: New predictions based on estimates of ‘Peak P’ and rock phosphate resources
- Author
-
Willey, Neil and Timbs, Patrick
- Published
- 2022
- Full Text
- View/download PDF
8. AI AT THE INTERSECTION BETWEEN TECHNOLOGY AND CREATIVITY
- Author
-
Timbs, Alex
- Subjects
Business ,Economics - Abstract
We are in an era of unprecedented technological progress across sectors, with artificial intelligence (AI) at the helm. AI unlocks extraordinary storytelling and artistic potential. It empowers creators with enhanced [...]
- Published
- 2023
9. Characterisation of genetic complexity in chronic lymphocytic leukaemia
- Author
-
Timbs, Adele T., Schuh, Anna, and Brooks, Susan
- Subjects
616.99 - Abstract
Chronic lymphocytic leukaemia (CLL) is the most common adult leukaemia in the Western world, characterised by the accumulation of mature B-cells. The disease has a heterogeneous course whereby some patients do not require treatment for several years while others follow a more aggressive disease progression and require early therapeutic action. Although several prognostic markers have been described, it is still difficult to predict the prognosis of the disease at diagnosis or to explain the diversity associated with the disease. The goal of this thesis was therefore, to characterise the genomic complexity and molecular drivers of clonal expansion and maintenance of CLL using targeted next generation sequencing (NGS) and high resolution single nucleotide polymorphism (SNP) array. NGS analysis of the immunoglobulin variable heavy-chain (IgHV) in 497 pre-treatment CLL patients found IgHV subclones in 18.5%, far higher than previously reported. SNP array analysis in 411 CLL patients refined the minimally overlapping regions (MOR) on del(6q) to the ATG5 and PRDM1 genes. Further autophagy related genes were also found to be present in other MORs. Analysis of the autophagy pathway at the protein level showed higher autophagy activity in primary CLL cells compared with age-matched controls. NGS-IgHV enabled the existing Sanger-sequencing based prognostic system to be refined. Correlation to the clinical outcome data showed that this new classification was prognostically significant. Furthermore, the identification of IgHV subclones imply that the leukaemia initiating event in CLL takes place prior to recombination. Concurrently, the detection of altered autophagy levels suggests a role for autophagy in CLL. Collectively these data provide new insights into the pathogenesis of CLL.
- Published
- 2017
- Full Text
- View/download PDF
10. Changes in the spatial distribution and anatomy of a range shift for the Atlantic surfclam Spisula solidissima in the Mid-Atlantic Bight and on Georges Bank
- Author
-
Timbs, Jeremy R., Powell, Eric N., and Mann, Roger
- Published
- 2019
11. Application of Genomics to Clinical Practice in Haematological Malignancy
- Author
-
Veenstra, Coen, Bruce, David, Timbs, Adele, and Hamblin, Angela
- Published
- 2019
- Full Text
- View/download PDF
12. AI AT THE INTERSECTION BETWEEN TECHNOLOGY AND CREATIVITY
- Author
-
Timbs, Alex
- Subjects
Business ,Economics - Abstract
We are in an era of unprecedented technological progress across sectors, with artificial intelligence (AI) at the helm. AI unlocks extraordinary storytelling and artistic potential. It empowers creators with enhanced [...]
- Published
- 2024
13. 227Ac Content in Tri-Lab Accelerator-Produced 225Ac: 2023 Update
- Author
-
Burgoyne, Andrew, primary, Ramos, Emily, additional, Wyant, Lance, additional, Denton, David, additional, Goldstein, Kari, additional, Peacock, Allison, additional, Gaddis, Kevin, additional, Jackson, Amanda, additional, Widner, Summer, additional, Molnar, Mikayla, additional, Timbs, Stephanie, additional, Kimberlin, Ashleigh, additional, Griswold, Justin, additional, Copping, Roy, additional, Stracener, Dan, additional, Medvedev, Dmitri, additional, Cutler, Cathy, additional, Vermeulen, Christiaan, additional, O’Brien, Ellen, additional, and Fassbender, Michael, additional
- Published
- 2023
- Full Text
- View/download PDF
14. Lower Self‐Control Is Associated With More Standard, Reputation Management, and Maladaptive Facebook Use
- Author
-
Maranges, Heather M., primary, Haddad, Nour, additional, Psihogios, Sarah, additional, Timbs, Casey L., additional, Gobes, Carina M., additional, and Preston, Thomas J., additional
- Published
- 2023
- Full Text
- View/download PDF
15. Science Curiosities
- Author
-
John Timbs
- Published
- 2019
16. ASSESSMENT OF THE RELATIONSHIP OF STOCK AND RECRUITMENT IN THE ATLANTIC SURFCLAM SPISULA SOLIDISSIMA IN THE NORTHWESTERN ATLANTIC OCEAN
- Author
-
Timbs, Jeremy R., Powell, Eric N., and Mann, Roger
- Subjects
Clam fisheries -- Research ,Population biology -- Research ,Fishery research ,Biological sciences ,Zoology and wildlife conservation - Abstract
Atlantic surfclams support a major commercial fishery in the western North Atlantic Ocean with landings consistently between 15,000 and 25,000 metric tons since 1982. The stock is not and historically has not been overfished nor has overfishing occurred; however, in recent years landings per unit effort have declined. Surfclams are a biomass dominant on the continental shelf and a bellwether of climate change in the northwestern Atlantic. This study investigated the relationship of broodstock and recruitment during a period when Mid-Atlantic warming initiated a shelf-wide shift in the surfclams range. A species distribution function model was used to assess the effective area occupied by surfclams for five study regions (Delmarva, New Jersey, Long Island, Southern New England, and Georges Bank). The effective area occupied by small surfclams was consistently much greater than that for large ([greater than or equal to] 120 mm) surfclams. Three independent statistical analyses of the stock-recruitment relationship found little evidence of a significant association in any of the five regions, suggesting that factors besides spawning stock biomass (SSB) are primary determinants of recruitment success. Interannual variability in recruitment, in part associated with variations in larval transport and in part associated with spatially different rates of mortality post-settlement, is an important source of uncertainty and warming bottom waters driving surfclams into new habitat may decouple any inherent interaction between recruits and SSB. A recruitment index obtained from a fishery-independent survey across the range of the stock, as a consequence, is unlikely to usefully presage changes in abundance of the fishable stock. The wider distribution of settlers relative to the fishable stock, however, positions the species well to respond to changing bottom water temperatures as Mid-Atlantic warming continues.KEY WORDS: ocean warming, clam fishery, effective area, biomass dominant, spawning stock biomass, recruitment index, Spisula solidissima, INTRODUCTIONAtlantic surfclams Spisula solidissima support a major commercial fishery in the western North Atlantic Ocean. Around 20,000 metric tons of surfclam meat were landed in 2015 with landings consistently between [...]
- Published
- 2018
- Full Text
- View/download PDF
17. Disasters and the Diminishing of Women's Economic Empowerment
- Author
-
Kreutzer, Willow, primary, Millerd, Carly, additional, and Timbs, Nathan, additional
- Published
- 2023
- Full Text
- View/download PDF
18. The Politics of the Penis: Post-Apartheid Zulu Nationalism and Martial Masculinity, ca 1999 to 2018
- Author
-
Timbs, Liz, primary
- Published
- 2023
- Full Text
- View/download PDF
19. Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia
- Author
-
Lynn Quek, Paul Ferguson, Marlen Metzner, Ikhlaaq Ahmed, Alison Kennedy, Catherine Garnett, Sally Jeffries, Claudia Walter, Kim Piechocki, Adele Timbs, Robert Danby, Manoj Raghavan, Andrew Peniket, Mike Griffiths, Andrew Bacon, Janice Ward, Keith Wheatley, Paresh Vyas, and Charles Craddock
- Subjects
Specialties of internal medicine ,RC581-951 - Abstract
Abstract: Disease relapse is the major cause of treatment failure after allogeneic stem cell transplantation (allo-SCT) in acute myeloid leukemia (AML). To identify AML-associated genes prognostic of AML relapse post–allo-SCT, we resequenced 35 genes in 113 adults at diagnosis, 49 of whom relapsed. Two hundred sixty-two mutations were detected in 102/113 (90%) patients. An increased risk of relapse was observed in patients with mutations in WT1 (P = .018), DNMT3A (P = .045), FLT3 ITD (P = .071), and TP53 (P = .06), whereas mutations in IDH1 were associated with a reduced risk of disease relapse (P = .018). In 29 patients, we additionally compared mutational profiles in bone marrow at diagnosis and relapse to study changes in clonal structure at relapse. In 13/29 patients, mutational profiles altered at relapse. In 9 patients, mutations present at relapse were not detected at diagnosis. In 15 patients, additional available pre–allo-SCT samples demonstrated that mutations identified posttransplant but not at diagnosis were detectable immediately prior to transplant in 2 of 15 patients. Taken together, these observations, if confirmed in larger studies, have the potential to inform the design of novel strategies to reduce posttransplant relapse highlighting the potential importance of post–allo-SCT interventions with a broad antitumor specificity in contrast to targeted therapies based on mutational profile at diagnosis.
- Published
- 2016
- Full Text
- View/download PDF
20. Disasters and the diminishing of women's economic empowerment
- Author
-
Willow Kreutzer, Carly Millerd, and Nathan Timbs
- Subjects
General Earth and Planetary Sciences ,General Social Sciences - Published
- 2023
21. Supplementary Data Tables from The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study
- Author
-
Anna Schuh, Hélène Dreau, Andreas Heger, David Sims, Fritz Offner, Bruno Verhasselt, Jan Philippé, André Efira, Virginie De Wilde, Marie Maerevoet, Radu Firescu, Philippe Mineur, Nathalie Meuleman, Peter Hillmen, David Bruce, Adele Timbs, Adam Burns, Pauline Robbe, Marek Mraz, Ruth Clifford, Karlien Pieters, Emerence Crompot, Thomas Smith, and Basile Stamatopoulos
- Abstract
Supplementary Data Table S1: general characterisctic of the different cohorts of patients Supplementary Data Table S2: characterisctic of Population A Supplementary Data Table S3: characterisctic of Population B Supplementary Data Table S4: characterisctic of Population C Supplementary Data Table S5: characterisctic of Population D Supplementary Data Table S6: Primer sequences Supplementary Data Table S7: Differentially expressed transcripts between IgLV3-21 + and - patients Supplementary Data Table S8: differentially expressed genes between IgLV3-21 + and - patients Supplementary Data Table S9: differentially expressed genes between IgLV3-21 + and - patients. Restricted to absolute fold-change > 1.5 and protein coding genes only Supplementary Data Table S10 Gene set Enrichment analysis between IgLV3-21 positive and negative patients
- Published
- 2023
22. Data from The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study
- Author
-
Anna Schuh, Hélène Dreau, Andreas Heger, David Sims, Fritz Offner, Bruno Verhasselt, Jan Philippé, André Efira, Virginie De Wilde, Marie Maerevoet, Radu Firescu, Philippe Mineur, Nathalie Meuleman, Peter Hillmen, David Bruce, Adele Timbs, Adam Burns, Pauline Robbe, Marek Mraz, Ruth Clifford, Karlien Pieters, Emerence Crompot, Thomas Smith, and Basile Stamatopoulos
- Abstract
Purpose: Unmutated (UM) immunoglobulin heavy chain variable region (IgHV) status or IgHV3-21 gene usage is associated with poor prognosis in chronic lymphocytic leukemia (CLL) patients. Interestingly, IgHV3-21 is often co-expressed with light chain IgLV3-21, which is potentially able to trigger cell-autonomous BCR-mediated signaling. However, this light chain has never been characterized independently of the heavy chain IgHV3-21.Experimental Design: We performed total RNA sequencing in 32 patients and investigated IgLV3-21 prognostic impact in terms of treatment-free survival (TFS) and overall survival (OS) in 3 other independent cohorts for a total of 813 patients. IgLV3-21 presence was tested by real-time PCR and confirmed by Sanger sequencing.Results: Using total RNA sequencing to characterize 32 patients with high-risk CLL, we found a high frequency (28%) of IgLV3-21 rearrangements. Gene set enrichment analysis revealed that these patients express higher levels of genes responsible for ribosome biogenesis and translation initiation (P < 0.0001) as well as MYC target genes (P = 0.0003). Patients with IgLV3-21 rearrangements displayed a significantly shorter TFS and OS (P < 0.05), particularly those with IgHV mutation. In each of the three independent validation cohorts, we showed that IgLV3-21 rearrangements—similar to UM IgHV status—conferred poor prognosis compared with mutated IgHV (P < 0.0001). Importantly, we confirmed by multivariate analysis that this was independent of IgHV mutational status or subset #2 stereotyped receptor (P < 0.0001).Conclusions: We have demonstrated for the first time that a light chain can affect CLL prognosis and that IgLV3-21 light chain usage defines a new subgroup of CLL patients with poor prognosis. Clin Cancer Res; 24(20); 5048–57. ©2018 AACR.
- Published
- 2023
23. Supplementary Data from The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study
- Author
-
Anna Schuh, Hélène Dreau, Andreas Heger, David Sims, Fritz Offner, Bruno Verhasselt, Jan Philippé, André Efira, Virginie De Wilde, Marie Maerevoet, Radu Firescu, Philippe Mineur, Nathalie Meuleman, Peter Hillmen, David Bruce, Adele Timbs, Adam Burns, Pauline Robbe, Marek Mraz, Ruth Clifford, Karlien Pieters, Emerence Crompot, Thomas Smith, and Basile Stamatopoulos
- Abstract
Supplementary Data Figure S1. Determination of IgLV3-21 positivity by real-time PCR. Supplementary Data Figure S2: CLL-OS analysis including only CLL-related deaths. Supplementary Data Figure S3. Validation of the poor prognosis associated with IgLV3-21 usage in population C. Supplementary Data Figure S4. Validation of the poor prognosis of IgLV3-21 usage in population D. Supplementary Data Figure S5: prognostic impact of IgLV3-21 usage in the different CLL-IPI subgroups. Supplementary Data Figure S6. Immunogenetic features of IgLV3-21 patients. Supplementary Data Figure S7. CXCR4 surface expression is downregulated in IgLV3-21 patients.
- Published
- 2023
24. P-322 - 227Ac Content in Tri-Lab Accelerator-Produced 225Ac: 2023 Update
- Author
-
Burgoyne, Andrew, Ramos, Emily, Wyant, Lance, Denton, David, Goldstein, Kari, Peacock, Allison, Gaddis, Kevin, Jackson, Amanda, Widner, Summer, Molnar, Mikayla, Timbs, Stephanie, Kimberlin, Ashleigh, Griswold, Justin, Copping, Roy, Stracener, Dan, Medvedev, Dmitri, Cutler, Cathy, Vermeulen, Christiaan, O’Brien, Ellen, and Fassbender, Michael
- Published
- 2023
- Full Text
- View/download PDF
25. HOW A VETERAN PIPELINE ENGINEER ACCELERATED NEXT-GENERATION MEDIA WORKLOADS WITH DELL POWERSCALE
- Author
-
Timbs, Alex
- Subjects
Engineers ,Business ,Economics - Abstract
Yan Chen, a 25-year film veteran and the CEO and founder of Aurora AI, has made a career out of bringing creative visions to life. Now, faced with a budding [...]
- Published
- 2023
26. Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL
- Author
-
Guièze, Romain, Robbe, Pauline, Clifford, Ruth, de Guibert, Sophie, Pereira, Bruno, Timbs, Adele, Dilhuydy, Marie-Sarah, Cabes, Maite, Ysebaert, Loïc, Burns, Adam, Nguyen-Khac, Florence, Davi, Frédéric, Véronèse, Lauren, Combes, Patricia, Le Garff-Tavernier, Magali, Leblond, Véronique, Merle-Béral, Hélène, Alsolami, Reem, Hamblin, Angela, Mason, Joanne, Pettitt, Andrew, Hillmen, Peter, Taylor, Jenny, Knight, SamanthaJ.L., Tournilhac, Olivier, and Schuh, Anna
- Published
- 2015
- Full Text
- View/download PDF
27. Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia
- Author
-
Stamatopoulos, B, Timbs, A, Bruce, D, Smith, T, Clifford, R, Robbe, P, Burns, A, Vavoulis, D V, Lopez, L, Antoniou, P, Mason, J, Dreau, H, and Schuh, A
- Published
- 2017
- Full Text
- View/download PDF
28. New challenges in diagnosis of haemoglobinopathies: Migration of populations
- Author
-
John Old, Adele Timbs, Janice McCarthy, Alice Gallienne, Melanie Proven, Michelle Rugless, Herminio Lopez, Jennifer Eglinton, Dariusz Dziedzic, Matthew Beardsall, Mohamed S.M. Khalila, and Shirley Henderson
- Subjects
Thalassemia ,Hemoglobinopathies. ,Diseases of the blood and blood-forming organs ,RC633-647.5 - Abstract
The current influx of economic migrants and asylum seekers from countries with a high prevalence of haemoglobinopathies creates new challenges for health care systems and diagnostic laboratories. The migration of carriers introduces new and novel haemoglobinopathy mutations to the diagnostic repertoire of a laboratory, often creating new pressures to improve and update the carrier screening technology and diagnostic scope. For antenatal screening programmes, the marriage of partners from different ethnic groups can lead to the risk of compound heterozygote children being born novel mutation combinations, creating problems in the provision of accurate advice regarding the expected phenotype of the thalassaemia or haemoglobinopathy disorder. In the UK, the impact of immigration required the National Haemoglobinopathy Reference laboratory to change the strategy and techniques used for the molecular diagnosis of thalassaemia and the haemoglobinopathies. In 2005, due to the increasingly large range of β-thalassaemia mutations that needed to be diagnosed, the laboratory switched from a three-step screening procedure using ARMS-PCR to a simpler but more expensive one-step strategy of DNA sequencing of the beta and alpha globin genes for all referrals. After ten years of employing this strategy, a further 57 novel thalassaemia and haemoglobionpopthy alleles were discovered (11 new β-chain variants, 15 α-chain variants, 19 β-thalassaemia mutations and 12 α+-thalassaemia mutations), increasing further the extremely heterogeneous spectrum of globin gene mutations in the UK population.
- Published
- 2018
- Full Text
- View/download PDF
29. Effectiveness of Knowledge Translation Strategies on Organisational Culture and Patient Outcomes: A Systematic Review
- Author
-
Tracy Flenady, Ashlyn Sahay, Chrissie Timbs, and Deb Massey
- Abstract
Background: Knowledge Translation (KT) Frameworks are commonly used in healthcare settings to integrate evidence into practice. However, little is known about how these KT frameworks affect organisational change including culture and patient safety outcomes in healthcare settings. Methods: A systematic review was undertaken. Five databases: PubMed, CINAHL, Scopus, ProQuest and Web of Science were searched with publications screened from January 2016 – July 2021. A blinded screening process was undertaken by all authors and conflicts resolved through open discussion. The Mixed Methods Appraisal Tool (MMAT) was used for quality appraisal. Results: Database search yielded a total of 1498 results, with only four studies included for data extraction and narrative synthesis. Three studies reported on patient safety outcomes, using Translational Simulation, Comprehensive Unit-based Safety Program (CUSP)/ Translating Research Into Practice (TRIP) model and the Consolidated Framework for Implementation Research (CFIR) framework. Only one study reported on organisational culture and used the Best-Practice Spotlight Organization (BPSO) Program. Factors that inhibited successful KT framework implementation relate to organisational and workforce issues such as staff attrition and secondments, staff not being released for education and an absence of commitment to the program at the executive level. Establishing and maintaining effective lines of communication and transparent reporting resulted in successful implementation outcomes. Conclusion: Various KT frameworks and strategies are used across healthcare settings to guide the development and evaluation of implementation projects and quality improvement initiatives. However, the impact of knowledge translation strategies on organisational culture and patient outcomes remains unclear, poorly described and under researched. Future research needs to be undertaken to explore the barriers and facilitators of knowledge translation processes and its impact on organisational change, culture and patient safety outcomes. Protocol Registration: This review was registered with the international prospective register of systematic reviews (PROSPERO), ID: CRD42021265470on 02/07/21. The design and methods used for this systematic review will be informed by and comply with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) (Moher et al., 2015).
- Published
- 2022
30. The Past, Present, and Future of African Opera - African Theatre 19: Opera & Music Theatre By Christine Mazke, Lena van der Hoven, Christopher Odhiambo, and Hilde Roos (eds.). Rochester, NY: James Currey, 2020. Pp. 262. $99.00, hardcover (ISBN: 9781847012579); $24.99, e-book (ISBN: 9781787449503)
- Author
-
Liz Timbs
- Subjects
History - Published
- 2022
31. Effectiveness of Knowledge Translation Strategies on Organisational Culture and Patient Outcomes: A Systematic Review
- Author
-
Flenady, Tracy, primary, Sahay, Ashlyn, additional, Timbs, Chrissie, additional, and Massey, Deb, additional
- Published
- 2022
- Full Text
- View/download PDF
32. SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage
- Author
-
Clifford, Ruth, Louis, Tania, Robbe, Pauline, Ackroyd, Sam, Burns, Adam, Timbs, Adele T., Wright Colopy, Glen, Dreau, Helene, Sigaux, Francois, Judde, Jean Gabriel, Rotger, Margalida, Telenti, Amalio, Lin, Yea-Lih, Pasero, Philippe, Maelfait, Jonathan, Titsias, Michalis, Cohen, Dena R., Henderson, Shirley J., Ross, Mark T., Bentley, David, Hillmen, Peter, Pettitt, Andrew, Rehwinkel, Jan, Knight, Samantha J.L., Taylor, Jenny C., Crow, Yanick J., Benkirane, Monsef, and Schuh, Anna
- Published
- 2014
- Full Text
- View/download PDF
33. Landscape-scale variation in a sulfur-based sediment stress indicator for the seagrass Thalassia testudinum in Florida Bay, USA
- Author
-
Riley Timbs and Michael J. Durako
- Subjects
0106 biological sciences ,chemistry.chemical_classification ,010504 meteorology & atmospheric sciences ,Ecology ,Sulfide ,biology ,010604 marine biology & hydrobiology ,chemistry.chemical_element ,Sediment ,Aquatic Science ,Stress indicator ,biology.organism_classification ,01 natural sciences ,Sulfur ,Oceanography ,Seagrass ,chemistry ,Thalassia testudinum ,Scale variation ,Environmental science ,Bay ,Ecology, Evolution, Behavior and Systematics ,0105 earth and related environmental sciences - Abstract
Intrusion of sediment-derived hydrogen sulfide into above-ground tissues of seagrasses is correlated with reduced growth and has been linked to large-scale die-offs of Thalassia testudinum in Florida Bay, USA. In May of 2019, leaves from T. testudinum short shoots at 350 sites within 13 basins across Florida Bay were collected to investigate bay-wide variation in a novel, stable sulfur isotope-based indicator of hydrogen sulfide intrusion [(δ34Sleaf + 30)/total sulfur content]. The components of this sediment stress indicator (SSI), total sulfur content (% dry weight) and δ34S, were negatively correlated (R2 = -0.24), indicating greater sediment sulfide exposure in plants with higher sulfur content. Generalized additive model selection revealed that SSI was best predicted by a model which included T. testudinum cover, sediment depth, and Halodule wrightii cover (R2 = 0.24, weight = 0.48). Macrophyte communities dominated by dense T. testudinum climax communities and with deep sediments, which are characteristics associated with die-off, had the lowest SSI values, indicating greatest sulfide intrusion. Sites within the area of a recent (2015) seagrass die-off had significantly higher SSI values than nearby, non-die-off-affected sites (mean ± SE: 44.1 ± 1.5 vs. 40.2 ± 1.6, Wilcoxon p < 0.05). The recent die-off sites also had lower T. testudinum cover and higher H. wrightii cover than the non-die-off sites, indicating they were in the midst of recovery and at an early successional stage. Our findings indicate that SSI may provide a minimally destructive indicator of chronic sulfide intrusion in T. testudinum in Florida Bay.
- Published
- 2021
34. King Zwelithini and the Historians
- Author
-
Jabulani Sithole, Jill E. Kelly, and Liz Timbs
- Subjects
History ,Goodwill ,language ,Zulu ,Historiography ,Ancient history ,language.human_language - Abstract
In the wake of the death of King Goodwill Zwelithini on 12 March 2021, three historians of KwaZulu-Natal came together to discuss the historiography on the Zulu monarchs. Jabulani Sithole (JS), Liz...
- Published
- 2021
35. New Opportunities: Teacher Librarians Managing Learning Objects
- Author
-
Judith Timbs
- Subjects
Critical mass (sociodynamics) ,World Wide Web ,Teacher-librarian ,Disparate system ,Computer science ,media_common.quotation_subject ,Professional learning community ,Interoperability ,ComputingMilieux_COMPUTERSANDEDUCATION ,Systems architecture ,Digital learning ,Function (engineering) ,media_common - Abstract
Digital learning objects are new kinds of resources which teacher librarians will be required to manage and make accessible to teachers and students. In Australia there are currently large-scale national and state initiatives underway to develop a critical mass of learning objects. The development of a Learning System Architecture has also become a vital step to make it possible to manage these learning objects. Packages that will enable students and teachers to communicate, collaborate, locate and access resources within intellectual property arrangements, assemble digital resources into learning sequences, assess and report are all necessary requirements. The Learning System Architecture emerging in Australia enables these disparate systems to function together as seamless and interoperable packages. A new profile of teacher librarian competency is being developed in Tasmania to assist with planning the professional learning needs of this group. The new profile includes understandings and experience of information communication technologies and online learning. Managing these new digital resources to support the teaching and learning is a key new professional role for teacher librarians.
- Published
- 2021
36. Compassionate use of remdesivir for patients with severe Covid-19
- Author
-
Grein, J, Ohmagari, N, Shin, D, Diaz, G, Asperges, E, Castagna, A, Feldt, T, Green, G, Green, M, Lescure, F, Nicastri, E, Oda, R, Yo, K, Quiros-Roldan, E, Studemeister, A, Redinski, J, Ahmed, S, Bernett, J, Chelliah, D, Chen, D, Chihara, S, Cohen, S, Cunningham, J, D'Arminio Monforte, A, Ismail, S, Kato, H, Lapadula, G, L'Her, E, Maeno, T, Majumder, S, Massari, M, Mora-Rillo, M, Mutoh, Y, Nguyen, D, Verweij, E, Zoufaly, A, Osinusi, A, Dezure, A, Zhao, Y, Zhong, L, Chokkalingam, A, Elboudwarej, E, Telep, L, Timbs, L, Henne, I, Sellers, S, Cao, H, Tan, S, Winterbourne, L, Desai, P, Mera, R, Gaggar, A, Myers, R, Brainard, D, Childs, R, Flanigan, T, Grein J., Ohmagari N., Shin D., Diaz G., Asperges E., Castagna A., Feldt T., Green G., Green M. L., Lescure F. -X., Nicastri E., Oda R., Yo K., Quiros-Roldan E., Studemeister A., Redinski J., Ahmed S., Bernett J., Chelliah D., Chen D., Chihara S., Cohen S. H., Cunningham J., D'Arminio Monforte A., Ismail S., Kato H., Lapadula G., L'Her E., Maeno T., Majumder S., Massari M., Mora-Rillo M., Mutoh Y., Nguyen D., Verweij E., Zoufaly A., Osinusi A. O., DeZure A., Zhao Y., Zhong L., Chokkalingam A., Elboudwarej E., Telep L., Timbs L., Henne I., Sellers S., Cao H., Tan S. K., Winterbourne L., Desai P., Mera R., Gaggar A., Myers R. P., Brainard D. M., Childs R., Flanigan T., Grein, J, Ohmagari, N, Shin, D, Diaz, G, Asperges, E, Castagna, A, Feldt, T, Green, G, Green, M, Lescure, F, Nicastri, E, Oda, R, Yo, K, Quiros-Roldan, E, Studemeister, A, Redinski, J, Ahmed, S, Bernett, J, Chelliah, D, Chen, D, Chihara, S, Cohen, S, Cunningham, J, D'Arminio Monforte, A, Ismail, S, Kato, H, Lapadula, G, L'Her, E, Maeno, T, Majumder, S, Massari, M, Mora-Rillo, M, Mutoh, Y, Nguyen, D, Verweij, E, Zoufaly, A, Osinusi, A, Dezure, A, Zhao, Y, Zhong, L, Chokkalingam, A, Elboudwarej, E, Telep, L, Timbs, L, Henne, I, Sellers, S, Cao, H, Tan, S, Winterbourne, L, Desai, P, Mera, R, Gaggar, A, Myers, R, Brainard, D, Childs, R, Flanigan, T, Grein J., Ohmagari N., Shin D., Diaz G., Asperges E., Castagna A., Feldt T., Green G., Green M. L., Lescure F. -X., Nicastri E., Oda R., Yo K., Quiros-Roldan E., Studemeister A., Redinski J., Ahmed S., Bernett J., Chelliah D., Chen D., Chihara S., Cohen S. H., Cunningham J., D'Arminio Monforte A., Ismail S., Kato H., Lapadula G., L'Her E., Maeno T., Majumder S., Massari M., Mora-Rillo M., Mutoh Y., Nguyen D., Verweij E., Zoufaly A., Osinusi A. O., DeZure A., Zhao Y., Zhong L., Chokkalingam A., Elboudwarej E., Telep L., Timbs L., Henne I., Sellers S., Cao H., Tan S. K., Winterbourne L., Desai P., Mera R., Gaggar A., Myers R. P., Brainard D. M., Childs R., and Flanigan T.
- Abstract
BACKGROUND Remdesivir, a nucleotide analogue prodrug that inhibits viral RNA polymerases, has shown in vitro activity against SARS-CoV-2. METHODS We provided remdesivir on a compassionate-use basis to patients hospitalized with Covid-19, the illness caused by infection with SARS-CoV-2. Patients were those with confirmed SARS-CoV-2 infection who had an oxygen saturation of 94% or less while they were breathing ambient air or who were receiving oxygen support. Patients received a 10-day course of remdesivir, consisting of 200 mg administered intravenously on day 1, followed by 100 mg daily for the remaining 9 days of treatment. This report is based on data from patients who received remdesivir during the period from January 25, 2020, through March 7, 2020, and have clinical data for at least 1 subsequent day. RESULTS Of the 61 patients who received at least one dose of remdesivir, data from 8 could not be analyzed (including 7 patients with no post-treatment data and 1 with a dosing error). Of the 53 patients whose data were analyzed, 22 were in the United States, 22 in Europe or Canada, and 9 in Japan. At baseline, 30 patients (57%) were receiving mechanical ventilation and 4 (8%) were receiving extracorporeal membrane oxygenation. During a median follow-up of 18 days, 36 patients (68%) had an improvement in oxygen-support class, including 17 of 30 patients (57%) receiving mechanical ventilation who were extubated. A total of 25 patients (47%) were discharged, and 7 patients (13%) died; mortality was 18% (6 of 34) among patients receiving invasive ventilation and 5% (1 of 19) among those not receiving invasive ventilation. CONCLUSIONS In this cohort of patients hospitalized for severe Covid-19 who were treated with compassionate-use remdesivir, clinical improvement was observed in 36 of 53 patients (68%). Measurement of efficacy will require ongoing randomized, placebo-controlled trials of remdesivir therapy.
- Published
- 2020
37. Learning about other cultures : what is the impact on students? Changing the world, by changing people.
- Author
-
Timbs, Judith
- Published
- 2013
38. Eleven Cases of Hb J-Paris-I [HBA2: c.38C>A (or HBA1)]: A Stable α Chain Variant Elutes in the P3 Window on High-Performance Liquid Chromatography
- Author
-
Shirley Henderson, Anna Schuh, Mohamed M. Khalil, John Old, and Adele Timbs
- Subjects
chemistry.chemical_classification ,Alanine ,Chromatography ,Chemistry ,Elution ,Isoelectric focusing ,Biochemistry (medical) ,Clinical Biochemistry ,Hematology ,High-performance liquid chromatography ,Amino acid ,Polymorphism (computer science) ,Aspartic acid ,Hemoglobin ,Genetics (clinical) - Abstract
Hb J-Paris-I [HBA2: c.38C>A (or HBA1)] is a stable fast-moving hemoglobin (Hb) that elutes in the P3 window on high performance liquid chromatography (HPLC). The mutation can happen on either the α1- or α2-globin gene. Codon 12 changes from GCC to GAC to replace the alanine amino acid with aspartic acid. This change is external with no clinical significance. The elution in the P3 wave on HPLC can interfere with the glycated Hb assay by HPLC. In this study, data of 11 cases of Hb J-Paris-I were thoroughly presented. The majority of the cases were of Indian ethnicity. The mean value of Hb J-Paris-I on HPLC was 26.7 ± 2.0%. The retention time (RT) was 1.75 ± 0.03 min. The isoelectric focusing (IEF) mean value was -5.6 (range -6.1 to -4.9). Hb A2 was consistently reduced to 1.8 ± 0.3%. A fraction of 0.8% corresponding to the Hb A2-J-Paris-I (α2J-Paris-Iδ2) is likely to be concealed within the A0 peak of Hb A on HPLC. Interestingly, two cases were associated with two different polymorphisms [HBA2: c.-24C>G or Cap +14 (C>G) and HBA2: c.*136A>G polymorphism] without apparent effect on the variant expression.
- Published
- 2021
39. Compassionate Use of Remdesivir for Patients with Severe Covid-19
- Author
-
Jennifer Cunningham, Marta Mora-Rillo, Robert P. Myers, Gary M. Green, Polly Desai, Toshitaka Maeno, Antonella D’Arminio Monforte, Yoshikazu Mutoh, Emanuele Nicastri, Ilana Henne, Susanna K. Tan, Erika Asperges, Jonathan Grein, Saad Ismail, Alex Studemeister, Rentaro Oda, Anuj Gaggar, Anu Osinusi, Kikuo Yo, Erwan L’Her, Huyen Cao, Hideaki Kato, Duc Nguyen, Seema Ahmed, Daniel Shin, Marco Massari, John Redinski, Giuseppe Lapadula, Lijie Zhong, Shingo Chihara, Laura Telep, Alexander Zoufaly, Daniel Chelliah, Ewa Verweij, Timothy Flanigan, Lucinda Winterbourne, Robertino Mera, Eugenia Quiros-Roldan, Diana M. Brainard, Adam DeZure, Leighann Timbs, Norio Ohmagari, Stuart H. Cohen, Sumit Majumder, Richard Childs, François-Xavier Lescure, Jorge Bernett, Emon Elboudwarej, Yang Zhao, Anand Chokkalingam, Scott Sellers, George Diaz, Torsten Feldt, Margaret L. Green, Danny Chen, Antonella Castagna, Grein, J, Ohmagari, N, Shin, D, Diaz, G, Asperges, E, Castagna, A, Feldt, T, Green, G, Green, M, Lescure, F, Nicastri, E, Oda, R, Yo, K, Quiros-Roldan, E, Studemeister, A, Redinski, J, Ahmed, S, Bernett, J, Chelliah, D, Chen, D, Chihara, S, Cohen, S, Cunningham, J, D'Arminio Monforte, A, Ismail, S, Kato, H, Lapadula, G, L'Her, E, Maeno, T, Majumder, S, Massari, M, Mora-Rillo, M, Mutoh, Y, Nguyen, D, Verweij, E, Zoufaly, A, Osinusi, A, Dezure, A, Zhao, Y, Zhong, L, Chokkalingam, A, Elboudwarej, E, Telep, L, Timbs, L, Henne, I, Sellers, S, Cao, H, Tan, S, Winterbourne, L, Desai, P, Mera, R, Gaggar, A, Myers, R, Brainard, D, Childs, R, Flanigan, T, Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., Feldt, T., Green, G., Green, M. L., Lescure, F. -X., Nicastri, E., Oda, R., Yo, K., Quiros-Roldan, E., Studemeister, A., Redinski, J., Ahmed, S., Bernett, J., Chelliah, D., Chen, D., Chihara, S., Cohen, S. H., Cunningham, J., D'Arminio Monforte, A., Ismail, S., Kato, H., Lapadula, G., L'Her, E., Maeno, T., Majumder, S., Massari, M., Mora-Rillo, M., Mutoh, Y., Nguyen, D., Verweij, E., Zoufaly, A., Osinusi, A. O., Dezure, A., Zhao, Y., Zhong, L., Chokkalingam, A., Elboudwarej, E., Telep, L., Timbs, L., Henne, I., Sellers, S., Cao, H., Tan, S. K., Winterbourne, L., Desai, P., Mera, R., Gaggar, A., Myers, R. P., Brainard, D. M., Childs, R., and Flanigan, T.
- Subjects
Compassionate Use Trials ,Male ,viruses ,030204 cardiovascular system & hematology ,Pharmacology ,Medical and Health Sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Japan ,80 and over ,Medicine ,030212 general & internal medicine ,Viral ,Lung ,Polymerase ,Aged, 80 and over ,Alanine ,biology ,Respiration ,General Medicine ,Prodrug ,Middle Aged ,humanities ,Europe ,Infectious Diseases ,6.1 Pharmaceuticals ,Artificial ,Administration ,Original Article ,Administration, Intravenous ,Female ,Intravenous ,Coronavirus Infections ,Human ,Adenosine monophosphate ,United State ,Adult ,Canada ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Clinical Trials and Supportive Activities ,Pneumonia, Viral ,Administration, Intravenou ,Antiviral Agents ,03 medical and health sciences ,Betacoronavirus ,Young Adult ,Clinical Research ,General & Internal Medicine ,Humans ,Pandemics ,Aged ,Antiviral Agent ,Betacoronaviru ,Pandemic ,business.industry ,Coronavirus Infection ,SARS-CoV-2 ,Prevention ,Compassionate Use ,Evaluation of treatments and therapeutic interventions ,COVID-19 ,Pneumonia ,Respiration, Artificial ,In vitro ,Adenosine Monophosphate ,United States ,COVID-19 Drug Treatment ,Coronavirus ,Emerging Infectious Diseases ,Good Health and Well Being ,chemistry ,biology.protein ,business - Abstract
Background Remdesivir, a nucleotide analogue prodrug that inhibits viral RNA polymerases, has shown in vitro activity against SARS-CoV-2. Methods We provided remdesivir on a compassionate-use basis to patients hospitalized with Covid-19, the illness caused by infection with SARS-CoV-2. Patients were those with confirmed SARS-CoV-2 infection who had an oxygen saturation of 94% or less while they were breathing ambient air or who were receiving oxygen support. Patients received a 10-day course of remdesivir, consisting of 200 mg administered intravenously on day 1, followed by 100 mg daily for the remaining 9 days of treatment. This report is based on data from patients who received remdesivir during the period from January 25, 2020, through March 7, 2020, and have clinical data for at least 1 subsequent day. Results Of the 61 patients who received at least one dose of remdesivir, data from 8 could not be analyzed (including 7 patients with no post-treatment data and 1 with a dosing error). Of the 53 patients whose data were analyzed, 22 were in the United States, 22 in Europe or Canada, and 9 in Japan. At baseline, 30 patients (57%) were receiving mechanical ventilation and 4 (8%) were receiving extracorporeal membrane oxygenation. During a median follow-up of 18 days, 36 patients (68%) had an improvement in oxygen-support class, including 17 of 30 patients (57%) receiving mechanical ventilation who were extubated. A total of 25 patients (47%) were discharged, and 7 patients (13%) died; mortality was 18% (6 of 34) among patients receiving invasive ventilation and 5% (1 of 19) among those not receiving invasive ventilation. Conclusions In this cohort of patients hospitalized for severe Covid-19 who were treated with compassionate-use remdesivir, clinical improvement was observed in 36 of 53 patients (68%). Measurement of efficacy will require ongoing randomized, placebo-controlled trials of remdesivir therapy. (Funded by Gilead Sciences.)
- Published
- 2020
40. Correction: Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups
- Author
-
Burns, A, Alsolami, R, Becq, J, Stamatopoulos, B, Timbs, A, Bruce, D, Robbe, P, Vavoulis, D, Clifford, R, Cabes, M, Dreau, H, Taylor, J, Knight, S J L, Mansson, R, Bentley, D, Beekman, R, Martín-Subero, J I, Campo, E, Houlston, R S, Ridout, K E, and Schuh, A
- Published
- 2019
- Full Text
- View/download PDF
41. Eight Cases of Hb Winnipeg [HBA2: c.226G>T (or HBA1)]: A Detailed Study
- Author
-
Shirley Henderson, Mohamed Khalil, Anna Schuh, John Old, and Adele Timbs
- Subjects
Isoelectric focusing ,Polymorphism (computer science) ,Biochemistry (medical) ,Clinical Biochemistry ,Presumptive diagnosis ,Hematology ,Hemoglobin hb ,Hb Winnipeg ,Biology ,Molecular biology ,Gene ,Genetics (clinical) ,Total hemoglobin - Abstract
Hb Winnipeg [α75(EF4)Asp→Tyr (α2); HBA2: c.226G>T (or HBA1)] is a stable α-globin chain variant described in a few articles. The majority of reported cases in older articles were clustered in Canada. It can occur on both α1- and α2-globin genes and in different populations. In this study, eight cases of Hb Winnipeg were characterized by DNA sequencing during a wide-spectrum study of suspected α-globin gene variants collected in the United Kingdom. All cases detected peaked in the S window between 4.4 and 4.54 min. on high performance liquid chromatography (HPLC). The isoelectric focusing (IEF) averaged at 6.21 below Hb A. All the mutations were detected on the α1-globin gene except in one case. The ethnic origin of the majority of the patients was Canadian. Only one case was associated with the common polymorphism HBA2: c.-24C>G (or HBA1) [Cap +14 (C>G)] on both α-globin genes without any apparent effect on the variant expression. All cases were detected in a heterozygous state. Hb Winnipeg expression was consistently lower than the theoretical value for α chain variants, ranging between 11.8 and 15.8% of total hemoglobin (Hb). This study gave more details about Hb Winnipeg that may help in presumptive diagnosis, especially in routine laboratories.
- Published
- 2021
42. The Past, Present, and Future of African Opera - African Theatre 19: Opera & Music Theatre By Christine Mazke, Lena van der Hoven, Christopher Odhiambo, and Hilde Roos (eds.). Rochester, NY: James Currey, 2020. Pp. 262. $99.00, hardcover (ISBN: 9781847012579); $24.99, e-book (ISBN: 9781787449503).
- Author
-
Timbs, Liz, primary
- Published
- 2022
- Full Text
- View/download PDF
43. Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variants
- Author
-
Loong, Lucy, primary, Cubuk, Cankut, additional, Choi, Subin, additional, Allen, Sophie, additional, Torr, Beth, additional, Garrett, Alice, additional, Loveday, Chey, additional, Durkie, Miranda, additional, Callaway, Alison, additional, Burghel, George J., additional, Drummond, James, additional, Robinson, Rachel, additional, Berry, Ian R., additional, Wallace, Andrew, additional, Eccles, Diana M., additional, Tischkowitz, Marc, additional, Ellard, Sian, additional, Ware, James S., additional, Hanson, Helen, additional, Turnbull, Clare, additional, Samant, S., additional, Lucassen, A., additional, Znaczko, A., additional, Shaw, A., additional, Ansari, A., additional, Kumar, A., additional, Donaldson, A., additional, Murray, A., additional, Ross, A., additional, Taylor-Beadling, A., additional, Taylor, A., additional, Innes, A., additional, Brady, A., additional, Kulkarni, A., additional, Hogg, A.-C., additional, Bowden, A. Ramsay, additional, Hadonou, A., additional, Coad, B., additional, McIldowie, B., additional, Speight, B., additional, DeSouza, B., additional, Mullaney, B., additional, McKenna, C., additional, Brewer, C., additional, Olimpio, C., additional, Clabby, C., additional, Crosby, C., additional, Jenkins, C., additional, Armstrong, C., additional, Bowles, C., additional, Brooks, C., additional, Byrne, C., additional, Maurer, C., additional, Baralle, D., additional, Chubb, D., additional, Stobo, D., additional, Moore, D., additional, O'Sullivan, D., additional, Donnelly, D., additional, Randhawa, D., additional, Halliday, D., additional, Atkinson, E., additional, Baple, E., additional, Rauter, E., additional, Johnston, E., additional, Woodward, E., additional, Maher, E., additional, Sofianopoulou, E., additional, Petrides, E., additional, Lalloo, F., additional, McRonald, F., additional, Pelz, F., additional, Frayling, I., additional, Evans, G., additional, Corbett, G., additional, Rea, G., additional, Clouston, H., additional, Powell, H., additional, Williamson, H., additional, Carley, H., additional, Thomas, H.J.W., additional, Tomlinson, I., additional, Cook, J., additional, Hoyle, J., additional, Tellez, J., additional, Whitworth, J., additional, Williams, J., additional, Murray, J., additional, Campbell, J., additional, Tolmie, J., additional, Field, J., additional, Mason, J., additional, Burn, J., additional, Bruty, J., additional, Callaway, J., additional, Grant, J., additional, Del Rey Jimenez, J., additional, Pagan, J., additional, VanCampen, J., additional, Barwell, J., additional, Monahan, K., additional, Tatton-Brown, K., additional, Ong, K.-R., additional, Murphy, K., additional, Andrews, K., additional, Mokretar, K., additional, Cadoo, K., additional, Smith, K., additional, Baker, K., additional, Brown, K., additional, Reay, K., additional, McKay Bounford, K., additional, Bradshaw, K., additional, Russell, K., additional, Stone, K., additional, Snape, K., additional, Crookes, L., additional, Reed, L., additional, Taggart, L., additional, Yarram, L., additional, Cobbold, L., additional, Walker, L., additional, Hawkes, L., additional, Busby, L., additional, Izatt, L., additional, Kiely, L., additional, Hughes, L., additional, Side, L., additional, Sarkies, L., additional, Greenhalgh, K.-L., additional, Shanmugasundaram, M., additional, Duff, M., additional, Bartlett, M., additional, Watson, M., additional, Owens, M., additional, Bradford, M., additional, Huxley, M., additional, Slean, M., additional, Ryten, M., additional, Smith, M., additional, Ahmed, M., additional, Roberts, N., additional, O'Brien, C., additional, Middleton, O., additional, Tarpey, P., additional, Logan, P., additional, Dean, P., additional, May, P., additional, Brace, P., additional, Tredwell, R., additional, Harrison, R., additional, Hart, R., additional, Kirk, R., additional, Martin, R., additional, Nyanhete, R., additional, Wright, R., additional, Davidson, R., additional, Cleaver, R., additional, Talukdar, S., additional, Butler, S., additional, Sampson, J., additional, Ribeiro, S., additional, Dell, S., additional, Mackenzie, S., additional, Hegarty, S., additional, Albaba, S., additional, McKee, S., additional, Palmer-Smith, S., additional, Heggarty, S., additional, MacParland, S., additional, Greville-Heygate, S., additional, Daniels, S., additional, Prapa, S., additional, Abbs, S., additional, Tennant, S., additional, Hardy, S., additional, MacMahon, S., additional, McVeigh, T., additional, Foo, T., additional, Bedenham, T., additional, Cranston, T., additional, McDevitt, T., additional, Clowes, V., additional, Tripathi, V., additional, McConnell, V., additional, Woodwaer, N., additional, Wallis, Y., additional, Kemp, Z., additional, Mullan, G., additional, Pierson, L., additional, Rainey, L., additional, Joyce, C., additional, Timbs, A., additional, Reuther, A.-M., additional, Frugtniet, B., additional, Husher, C., additional, Lawn, C., additional, Corbett, C., additional, Nocera-Jijon, D., additional, Reay, D., additional, Cross, E., additional, Ryan, F., additional, Lindsay, H., additional, Oliver, J., additional, Dring, J., additional, Spiers, J., additional, Harper, J., additional, Ciucias, K., additional, Connolly, L., additional, Tsang, M., additional, Brown, R., additional, Shepherd, S., additional, Begum, S., additional, Tadiso, T., additional, Linton-Willoughby, T., additional, Heppell, H., additional, Sahan, K., additional, Worrillow, L., additional, Allen, Z., additional, Barlett, M., additional, Watt, C., additional, and Hegarty, M., additional
- Published
- 2022
- Full Text
- View/download PDF
44. Graphic Interlude
- Author
-
Georgia Kuhn, Andrew J. Russell, Walker Evans, Carol M. Highsmith, Robert Bakewell, John Timbs, and Jack Delano
- Subjects
angles ,limes ,border ,photography ,History (General) and history of Europe ,English language ,PE1-3729 - Abstract
This graphic interlude features a selection of photographs which can illustrate the topic of this issue: “Angles and limes”.
- Published
- 2016
- Full Text
- View/download PDF
45. Fifteen Cases of Hb J-Meerut: The Rare Association with Hb E and/or HBA1: c.-24C>G (or HBA2) Variants
- Author
-
Mohamed Khalil, Adele Timbs, John Old, Anna Schuh, and Shirley Henderson
- Subjects
03 medical and health sciences ,0302 clinical medicine ,Chemistry ,030220 oncology & carcinogenesis ,Biochemistry (medical) ,Clinical Biochemistry ,Genetic variants ,Hematology ,Hemoglobin hb ,High-performance liquid chromatography ,Molecular biology ,Genetics (clinical) ,030215 immunology - Abstract
Hb J-Meerut [HBA2: c.362C>A (or HBA1)] is a rare, stable, nonpathogenic α-globin gene variant that peaks in the area between the P3 and A0 windows on high performance liquid chromatography (HPLC). ...
- Published
- 2020
46. A Wide Spectrum Study of α-Globin Chain Variants: Cases from the UK
- Author
-
Adele Timbs, John Old, Shirley Henderson, Mohamed Khalil, Anna Schuh, and Mohamed M. El-Khawanky
- Subjects
Erythrocyte Indices ,Genotype ,Clinical Biochemistry ,High-performance liquid chromatography ,DNA sequencing ,α globin ,03 medical and health sciences ,0302 clinical medicine ,Gene Frequency ,alpha-Globins ,alpha-Thalassemia ,Chain (algebraic topology) ,Humans ,α globin gene ,Codon ,Alleles ,Genetics (clinical) ,Chemistry ,Biochemistry (medical) ,Genetic Variation ,Exons ,Hematology ,Molecular biology ,United Kingdom ,Hemoglobinopathies ,Population Surveillance ,030220 oncology & carcinogenesis ,Mutation ,Hemoglobin hb ,030215 immunology - Abstract
Over many years, cases of suspected α-globin chain variants were collected from different parts of the UK. The suspicion was based on the clinical picture, high performance liquid chromatography (HPLC) variant percentage, retention time (RT) and isoelectric focusing (IEF). DNA sequencing and the restriction enzyme E
- Published
- 2020
47. Raising learners' metalinguistic awareness: an examination of students' academic writing development at university
- Author
-
Timbs, Sarah Jane
- Subjects
Other education not elsewhere classified - Abstract
This research project seeks to investigate the academic writing development of three students in the foundational first year unit ‘Academic Communication in Business and Economics’ (ACBE100) at Macquarie University. This unit aims to support students in their transition to university by enabling them to understand and achieve the necessary standards of performance required to be successful in an academic environment. This study was designed to be an intervention within the Macquarie Longitudinal Learner Corpus (MQLLC) research project currently being conducted by Dr Cassandra Liardet and her research team at Macquarie University. Participants are student volunteers studying the ACBE100 unit and were recruited from the larger MQLLC project. Writing development is explored from the students’ perspective through repeated use of a formative self-assessment tool, which aims to measure the accuracy with which the students are able to evaluate themselves in comparison to a researcher’s linguistic analysis of their written texts. Additionally, interviews regarding perspectives on the self assessment process were conducted with the students and a tutor. A linguistic perspective on the students’ writing development is provided through textual analysis encompassing genre, periodic structure and thematic development. These perspectives seek to illuminate the relationship between explicit teaching of linguistic features of academic writing and students’ writing development. This study employs a Systemic Functional Linguistics theoretical framework (see Halliday, 1993; Martin & Rose, 2008; Schleppegrell, 2001,2004) for mapping and examining language features.
- Published
- 2022
- Full Text
- View/download PDF
48. Eleven Cases of Hb J-Paris-I [
- Author
-
Mohamed S M, Khalil, Adele T, Timbs, Shirley J, Henderson, Anna, Schuh, and John M, Old
- Subjects
Glycated Hemoglobin ,Hemoglobin J ,Hemoglobinopathies ,Genotype ,alpha-Globins ,alpha-Thalassemia ,Hemoglobins, Abnormal ,Humans ,Hemoglobin A2 ,Chromatography, High Pressure Liquid - Abstract
Hb J-Paris-I [
- Published
- 2021
49. Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variants
- Author
-
Lucy Loong, Cankut Cubuk, Subin Choi, Sophie Allen, Beth Torr, Alice Garrett, Chey Loveday, Miranda Durkie, Alison Callaway, George J. Burghel, James Drummond, Rachel Robinson, Ian R. Berry, Andrew Wallace, Diana M. Eccles, Marc Tischkowitz, Sian Ellard, James S. Ware, Helen Hanson, Clare Turnbull, S. Samant, A. Lucassen, A. Znaczko, A. Shaw, A. Ansari, A. Kumar, A. Donaldson, A. Murray, A. Ross, A. Taylor-Beadling, A. Taylor, A. Innes, A. Brady, A. Kulkarni, A.-C. Hogg, A. Ramsay Bowden, A. Hadonou, B. Coad, B. McIldowie, B. Speight, B. DeSouza, B. Mullaney, C. McKenna, C. Brewer, C. Olimpio, C. Clabby, C. Crosby, C. Jenkins, C. Armstrong, C. Bowles, C. Brooks, C. Byrne, C. Maurer, D. Baralle, D. Chubb, D. Stobo, D. Moore, D. O'Sullivan, D. Donnelly, D. Randhawa, D. Halliday, E. Atkinson, E. Baple, E. Rauter, E. Johnston, E. Woodward, E. Maher, E. Sofianopoulou, E. Petrides, F. Lalloo, F. McRonald, F. Pelz, I. Frayling, G. Evans, G. Corbett, G. Rea, H. Clouston, H. Powell, H. Williamson, H. Carley, H.J.W. Thomas, I. Tomlinson, J. Cook, J. Hoyle, J. Tellez, J. Whitworth, J. Williams, J. Murray, J. Campbell, J. Tolmie, J. Field, J. Mason, J. Burn, J. Bruty, J. Callaway, J. Grant, J. Del Rey Jimenez, J. Pagan, J. VanCampen, J. Barwell, K. Monahan, K. Tatton-Brown, K.-R. Ong, K. Murphy, K. Andrews, K. Mokretar, K. Cadoo, K. Smith, K. Baker, K. Brown, K. Reay, K. McKay Bounford, K. Bradshaw, K. Russell, K. Stone, K. Snape, L. Crookes, L. Reed, L. Taggart, L. Yarram, L. Cobbold, L. Walker, L. Hawkes, L. Busby, L. Izatt, L. Kiely, L. Hughes, L. Side, L. Sarkies, K.-L. Greenhalgh, M. Shanmugasundaram, M. Duff, M. Bartlett, M. Watson, M. Owens, M. Bradford, M. Huxley, M. Slean, M. Ryten, M. Smith, M. Ahmed, N. Roberts, C. O'Brien, O. Middleton, P. Tarpey, P. Logan, P. Dean, P. May, P. Brace, R. Tredwell, R. Harrison, R. Hart, R. Kirk, R. Martin, R. Nyanhete, R. Wright, R. Davidson, R. Cleaver, S. Talukdar, S. Butler, J. Sampson, S. Ribeiro, S. Dell, S. Mackenzie, S. Hegarty, S. Albaba, S. McKee, S. Palmer-Smith, S. Heggarty, S. MacParland, S. Greville-Heygate, S. Daniels, S. Prapa, S. Abbs, S. Tennant, S. Hardy, S. MacMahon, T. McVeigh, T. Foo, T. Bedenham, T. Cranston, T. McDevitt, V. Clowes, V. Tripathi, V. McConnell, N. Woodwaer, Y. Wallis, Z. Kemp, G. Mullan, L. Pierson, L. Rainey, C. Joyce, A. Timbs, A.-M. Reuther, B. Frugtniet, C. Husher, C. Lawn, C. Corbett, D. Nocera-Jijon, D. Reay, E. Cross, F. Ryan, H. Lindsay, J. Oliver, J. Dring, J. Spiers, J. Harper, K. Ciucias, L. Connolly, M. Tsang, R. Brown, S. Shepherd, S. Begum, T. Tadiso, T. Linton-Willoughby, H. Heppell, K. Sahan, L. Worrillow, Z. Allen, M. Barlett, C. Watt, M. Hegarty, British Heart Foundation, and Wellcome Trust
- Subjects
Concordance ,Mutation, Missense ,Biology ,PM5 ,CanVIG-UK ,Humans ,Missense mutation ,Genetic Predisposition to Disease ,Variant ,Codon ,Genetics (clinical) ,Genetics ,Genetics & Heredity ,0604 Genetics ,BRCA1 Protein ,Genetic Variation ,1103 Clinical Sciences ,Pathogenicity ,Classification ,MutS Homolog 2 Protein ,Genetic Variation/genetics ,Mutation, Missense/genetics ,MSH2 ,ACMG ,BRCA1 Protein/genetics ,MutS Homolog 2 Protein/genetics - Abstract
Purpose: Conditions and thresholds applied for evidence weighting of within-codon concordance (PM5) for pathogenicity vary widely between laboratories and expert groups. Because of the sparseness of available clinical classifications, there is little evidence for variation in practice. Methods: We used as a truthset 7541 dichotomous functional classifications of BRCA1 and MSH2, spanning 311 codons of BRCA1 and 918 codons of MSH2, generated from large-scale functional assays that have been shown to correlate excellently with clinical classifications. We assessed PM5 at 5 stringencies with incorporation of 8 in silico tools. For each analysis, we quantified a positive likelihood ratio (pLR, true positive rate/false positive rate), the predictive value of PM5-lookup in ClinVar compared with the functional truthset. Results: pLR was 16.3 (10.6-24.9) for variants for which there was exactly 1 additional colocated deleterious variant on ClinVar, and the variant under examination was equally or more damaging when analyzed using BLOSUM62. pLR was 71.5 (37.8-135.3) for variants for which there were 2 or more colocated deleterious ClinVar variants, and the variant under examination was equally or more damaging than at least 1 colocated variant when analyzed using BLOSUM62. Conclusion: These analyses support the graded use of PM5, with potential to use it at higher evidence weighting where more stringent criteria are met.
- Published
- 2021
50. Eight Cases of Hb Winnipeg [
- Author
-
Mohamed S M, Khalil, Adele T, Timbs, Shirley J, Henderson, Anna, Schuh, and John M, Old
- Subjects
Glycated Hemoglobin ,Canada ,Genotype ,alpha-Globins ,alpha-Thalassemia ,Hemoglobins, Abnormal ,Mutation ,Humans ,Aged - Abstract
Hb Winnipeg [α75(EF4)Asp→Tyr (α2)
- Published
- 2021
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.